• Home
  • Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer.

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer.

Author List
Shastry M, Jacob S, Rugo HS, Hamilton E
Publication
Breast (Edinburgh, Scotland)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366107088
Publication Year
2022
PubMed ID
36302269
Publication Title
Shastry M, Jacob S, Rugo HS, Hamilton E. Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer. Breast. 2022 Dec; 66:169-177.